SCHEMBL9310765

SCHEMBL9310765

CCc1ccc2cccnc2c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
EGLN1 Q9GZT9 8/20 0.52
HSP90AA1 P07900 3/20 0.52
KDM4E B2RXH2 3/20 0.52
MMP2 P08253 2/20 0.52
TSHR P16473 2/20 0.52
GMNN O75496 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
MAPT P10636 1/20 0.52
MMP9 P14780 1/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
MMP8 P22894 1/20 0.52
CCR1 P32246 1/20 0.52
THPO P40225 1/20 0.52
MTOR P42345 1/20 0.52
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1714944 0.86 BCHE (0.49) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL31055818 0.85 BCHE (0.48) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL1824345 0.85 BCHE (0.48) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL1240579 0.82 BCHE (0.46) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL10705017 0.82 TRPV1 (0.49) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL15334550 0.82 BCHE (0.46) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL12722433 0.82 CTSB (0.53) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL31307163 0.82 BCHE (0.46) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL2359289 0.82 LMNA (0.52) ALDH1A1EGLN1HSP90AA1KDM4EMMP2
SCHEMBL8934158 0.81 BCHE (0.48) ALDH1A1EGLN1HSP90AA1KDM4EMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5294519-A Process for preparing printed-circuit board KANSAI PAINT CO., LTD. (JP) 1994-03-15 US claimed
US-20170334861-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2017-11-23 US disclosed
US-9302993-B2 8-hydroxy quinoline derivatives PRANA BIOTECHNOLOGY LIMITED (AU) 2016-04-05 US disclosed
US-20150335635-A1 8-HYDROXY QUINOLINE DERIVATIVES PRANA BIOTECHNOLOGY LIMITED (AU) 2015-11-26 US disclosed
CN-101412775-B Catalyst precursor for polymerization of propylene or combined polymerization, and preparation thereof BEIJING JINDINGKE CHEMICAL TECHNOLOGY CO LTD 2010-12-22 CN disclosed
CN-101139407-B Catalyst precursor for ethylene polymerization or copolymerization and preparation method thereof BEIJING JINDINGKE CHEMICAL TECHNOLOGY CO LTD 2010-10-06 CN disclosed
CN-101412775-A Catalyst activity component for polymerization of propylene or combined polymerization, catalyst precursor containing the same and preparation thereof BEIJING JINDINGKE CHEMICAL TEC (CN) 2009-04-22 CN disclosed
US-20080312435-A1 Imine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-18 US disclosed
CN-101139407-A Catalyst active component for ethylene polymerization or copolymerization and catalyst precursor comprising the active component and preparation method thereof BEIJING JINDINGKE CHEMICAL TEC (CN) 2008-03-12 CN disclosed
US-5294519-A Process for preparing printed-circuit board KANSAI PAINT CO., LTD. (JP) 1994-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312435-A1 Imine Compound CNR1, CNR2, HRH4 ALDH1A1 2674/4885EGLN1 1998/4885HSP90AA1 2112/4885
US-20150335635-A1 8-HYDROXY QUINOLINE DERIVATIVES PARK7, COQ8A, NLN ALDH1A1 725/4885EGLN1 1896/4885HSP90AA1 1187/4885
US-20170334861-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT3 ALDH1A1 1890/4885EGLN1 430/4885HSP90AA1 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.